School and focused on catecolamine pharmacology, particularly the role of epinephrine in brain. From Dartmouth, Jon moved to the Maryland Psychiatric Research Center (MPRC) in 1978; there, he headed the Neuroscience Program. He developed a strong scientific group of basic scientists organized around translational interests in brain diseases; today this division of the MPRC continues to carry out important, contributory translational research in neuroscience. Jon's research was focused on the characteristics of the synthetic enzymes in the norepinephrine and epinephrine pathways. In 1987, Jon left academia for industry, where he continued to focus on his passion for translating basic neuroscience to therapeutics. He was first employed at Upjohn Company in Kalamazoo for 2 years, moving to Quintiles in 1989. He worked for an extended period of time at Quintiles Inc., leaving in 1998. At Quintiles he focused on Phase 1 characterization of early treatment compounds. After 1998, Jon did private consultation and was a medical director at Kyowa. Jon loved the discovery and excitement of neuroscience research; he pursued the process of it, whether in academia or in industry with vision, honesty, and enthusiasm. Throughout his career, Jon served the scientific community through service on many university, federal, and society committees. Jon had many close colleagues working in the area of CNS pharmacology who remember his passion, critical mind, and love for family and friends. Jon became an ACNP member in 1982; like the rest of us, he loved the annual meeting and used the time for learning new science, networking with friends, and planning new experiments. Although many of us were familiar with his scientific work, other areas of his life were full as well. Jon was a devoted husband and father, a wonderful friend, and a dedicated craftsman and homebuilder. He had four children and three grandsons. He died peacefully on 20 December 2005 from renal cancer with his family at his side. The ACNP will miss the passing of such a steady friend and a good colleague.
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